UCSF Researchers Collaborate to Translate Discoveries into New Solutions for Advancing Health
By Jeffrey Norris | UCSF.edu | December 20, 2012
UCSF is a health-sciences research powerhouse – a premier academic medical center that values not only the physician who designs clinical trial protocols for promising experimental drugs, but also the talented lab scientist who unearths nature’s secrets on the molecular and cellular levels.
It's a place where basic scientists, population scientists and clinical researchers work together to translate basic biological discoveries into new solutions for preventing and treating human diseases.
The University also advances discovery through partnerships with business, industry and other research organizations. In the most recent tally, UCSF topped all other public universities in research funds awarded from the National Institutes of Health, the federal agency that – based on competitive review of research proposals – awards the bulk of federal health sciences research dollars.
> view full article
The UCSF Helen Diller Family Comprehensive Cancer Center received a major renewal grant from the NIH this year, and its researchers continue to make seminal discoveries across a wide spectrum of cancers.
Armed with a new $10 million grant to study advanced prostate cancer, UCSF will lead multi-center research that will focus on 500 patients to identify the causes of drug resistance in the disease, and to better tailor treatment to the individual.
To treat brain cancer, neurosurgeon Andrew Parsa, MD, PhD, found that a cancer vaccine shows promise in Phase II trials. Oncologists and surgeons have demonstrated ways to predict post-operative early-stage lung cancer mortality and determined that a molecular test can predict the likelihood of death from early-stage lung cancer more accurately than conventional methods.
A tean led by Eleni Linos, MD, DrPH, found that indoor tanning beds can cause non-melanoma skin cancer – and that the risk is greater the earlier one starts tanning.